hormonal contraception’s role in HIV infection

 About 75% of HIV-infected individuals in sub-Saharan African in between the ages of 15 and 24 are ladies. Many factors contribute in this sex discrepancy. These consist of gender-based social disparity and a high occurrence of intergenerational sex-related collaborations.


But research recommends certain kinds of hormone contraceptives commonly used in this area could also contribute.


Injectable progestin contraceptives, such as Depo-Provera, are especially popular in sub-Saharan Africa. They work and practical. Rather than taking an everyday tablet, ladies can receive Depo-Provera shots every 3 months.


But studies recommend that ladies using this specific kind of contraceptive are more vulnerable to HIV. Most recently a massive study conducted in Africa found ladies using injectable progestins were two times as most likely to obtain HIV compared to ladies using no hormone contraceptive.


This kind of study cannot show a particular kind of contraceptive actually makes ladies more vulnerable to infection, as it's simply looking for an organization in between both.


To really find out if contraceptives make ladies more vulnerable to infection, you need to see how these medications actually affect the systems that protect the body from infection. Such studies are harder to perform in people, so my associates and I decided to explore computer mouse models.


We used mice to learn if Depo-Provera or levonorgestrel (LNG), a progestin used in hormone intrauterine devices, affect the genital mucosal obstacle. This obstacle functions as a blockade to prevents infection and germs from contaminating body cells. In various other words, it's a very first line of protection versus infection.  Bermain Judi Sabung Ayam Terpercaya 2021



Epithelial cells externally of genital system cells are an essential part of this obstacle. They are held firmly with each other by adhesion particles that make it challenging for pathogens to penetrate cells and develop infection.


But we found that mice treated with Depo-Provera or LNG have lower degrees of several of these adhesion particles. This means that genital epithelial cells aren't held with each other as firmly, cells becomes more permeable and infection more easily invades.


Our research shows these contraceptives increase computer mouse vulnerability to infection. But do comparable changes in permeability also occur in ladies?


To find this out, we obtained cervical cells from US ladies before and after they began using Depo-Provera. This revealed Depo-Provera causes changes to adhesion particles and cells permeability just like those seen in mice.

Popular posts from this blog

The first ‘golden age’ of antibiotics

Online sex parties